These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


396 related items for PubMed ID: 12666957

  • 1. Update on Actinobacillus Actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease.
    Slots J.
    J Int Acad Periodontol; 1999 Oct; 1(4):121-6. PubMed ID: 12666957
    [Abstract] [Full Text] [Related]

  • 2. Transmission of periodontal bacteria and models of infection.
    Van Winkelhoff AJ, Boutaga K.
    J Clin Periodontol; 2005 Oct; 32 Suppl 6():16-27. PubMed ID: 16128826
    [Abstract] [Full Text] [Related]

  • 3. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis.
    López NJ.
    J Periodontol; 2000 Jun; 71(6):948-54. PubMed ID: 10914798
    [Abstract] [Full Text] [Related]

  • 4. Association between infection of different strains of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in subgingival plaque and clinical parameters in chronic periodontitis.
    Wu YM, Yan J, Chen LL, Gu ZY.
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):121-31. PubMed ID: 17266188
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
    Rams TE, Listgarten MA, Slots J.
    J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
    [Abstract] [Full Text] [Related]

  • 7. Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease.
    Mombelli A, Schmid B, Rutar A, Lang NP.
    J Periodontol; 2000 Jan; 71(1):14-21. PubMed ID: 10695934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy.
    Rodrigues RM, Gonçalves C, Souto R, Feres-Filho EJ, Uzeda M, Colombo AP.
    J Clin Periodontol; 2004 Jun; 31(6):420-7. PubMed ID: 15142209
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral ecology and person-to-person transmission of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis.
    Asikainen S, Chen C.
    Periodontol 2000; 1999 Jun; 20():65-81. PubMed ID: 10522223
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic utility of specific microbiological markers for periodontal diseases.
    Eggert FM, Flowerdew G, McLeod MH, McIntyre EW, Wasylyk J, Koschzeck L.
    J Periodontol; 1998 Dec; 69(12):1373-81. PubMed ID: 9926767
    [Abstract] [Full Text] [Related]

  • 15. Of mice and men: animal models of human periodontal disease.
    Fine DH.
    J Clin Periodontol; 2009 Nov; 36(11):913-4. PubMed ID: 19735469
    [No Abstract] [Full Text] [Related]

  • 16. The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis.
    Johansson A, Buhlin K, Koski R, Gustafsson A.
    Eur J Oral Sci; 2005 Jun; 113(3):197-202. PubMed ID: 15953243
    [Abstract] [Full Text] [Related]

  • 17. [Bacteriologic investigation of periodontal infections].
    Barna Z, Keglevich T, Gera I.
    Fogorv Sz; 2001 Jun; 94(3):97-100. PubMed ID: 11480243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adjunctive effects of systemic amoxicillin and metronidazole with scaling and root planing: a randomized, placebo controlled clinical trial.
    Moeintaghavi A, Talebi-ardakani MR, Haerian-ardakani A, Zandi H, Taghipour S, Fallahzadeh H, Pakzad A, Fahami N.
    J Contemp Dent Pract; 2007 Jul 01; 8(5):51-9. PubMed ID: 17618330
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.